News | July 28, 2010

St. Jude Files Patent Lawsuit Against Volcano Over FFR Wires


July 28, 2010 – This week St. Jude Medical filed a patent infringement lawsuit against Volcano Corp. over its fractional flow reserve (FFR) wires. The suit was filed in federal district court in Delaware. Volcano said the claims against it are entirely without merit.

The complaint alleges Volcano infringed on five St. Jude patents related to its PressureWire. St. Jude Medical seeks injunctive relief and monetary damages.

FFR is used to evaluate the severity of stenosis in arteries to determine if the lesions should be stented.

St. Jude Medical acquired its FFR technology with the purchase of Radi Medical Systems in December 2008. Volcano is the only other company that offers an FFR system that is cleared for use by the U.S. Food and Drug Administration (FDA).

In May, St. Jude acquired LightLab Imaging Inc., which is also engaged in litigation against Volcano and subsidiary Axsun Technologies Inc. in Suffolk County, Mass. LightLab developed an optical coherence tomography (OCT) intravascular imaging system, which received FDA clearance earlier this year. Volcano is also developing an OCT system and Axsun is a supplier for LightLab.

For more information: www.volcanocorp.com, www.sjm.com


Additional Content

News | FFR Technologies

Oct. 21, 2026 — The U.S. Food and Drug Administration (FDA) has cleared Elucid's FFR-IQ software for non-invasive ...

Home October 23, 2026
Home
Feature | FFR Technologies | Kyle Hardner

Editor's Note: This is Part Two of a three-part series highlighting several of the presentations from the American ...

Home April 30, 2026
Home
News | FFR Technologies

Feb. 3, 2026 — Medtronic plc announced it will exercise its option to acquire CathWorks, a privately held medical device ...

Home February 03, 2026
Home
News | FFR Technologies

Oct. 27, 2024 — HeartFlow, Inc. recently announced seven-year data confirming the use of HeartFlow’s AI-enabled ...

Home October 30, 2024
Home
News | FFR Technologies

June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy ...

Home June 04, 2024
Home
Subscribe Now